The impact of reporting a prior penicillin allergy on the treatment of methicillin-sensitive Staphylococcus aureus bacteremia

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Blumenthal, Kimberly G ^a,b   Shenoy, Erica S ^a,b   Huang, Mingshu ^a   Kuhlen, James L ^c   Ware, Winston A ^a   Parker, Robert A ^a,b   Walensky, Rochelle P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE GREENVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFTRIAXONE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; NAFCILLIN; OXACILLIN; PENICILLIN G; VANCOMYCIN; ANTIINFECTIVE AGENT; BETA LACTAM; METICILLIN; PENICILLIN DERIVATIVE;

ADULT; AGED; ARTICLE; BACTEREMIA; COHORT ANALYSIS; CONSULTATION; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS BACTEREMIA; OUTCOME ASSESSMENT; PENICILLIN ALLERGY; RETROSPECTIVE STUDY; STAPHYLOCOCCAL BACTEREMIA; DRUG EFFECTS; DRUG HYPERSENSITIVITY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; SKIN TEST; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; METHICILLIN; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; RETROSPECTIVE STUDIES; SKIN TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 84979578244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0159406     Document Type: Article

References (53)

1. Naidoo R, Nuttall J, Whitelaw A, Eley B. Epidemiology of Staphylococcus aureus bacteraemia at a tertiary children's hospital in Cape Town, South Africa. PLoS One. 22(8):e78396.
2. Fowler VG, Sexton DJ. Clinical approach to Staphylococcus aureus bacteremia in adults. In: Baron EL, ed. UpToDate. Waltham, MA: Wolters Kluwer; 2013. Accessed January 31, 2016.
3. Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2005; 26(2):175-183. PMID: 15756889
4. David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG, Miller LG, et al. Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections. Clin Infect Dis. 2014; 59(6):798-807. doi: 10.1093/cid/ciu410 PMID: 24879783
5. Saunderson RB, Gouliouris T, Nickerson EK, Cartwright EJ, Kidney A, Aliyu SH, et al. Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults. Clin Microbiol Infect. 2015; 21(8):779-785. doi: 10.1016/j.cmi.2015.05.026 PMID: 26033668
6. Fowler VG, Sexton DJ. Treatment of Staphylococcus aureus bacteremia in adults. In: Baron EL, ed. UptoDate. Watham, MA: Wolters Kluwer; 2013.
7. Tom S, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, Schønheyder HC, et al. Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2014; 20(10):630-632.
8. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Disease Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011; 52:1-38.
9. Lee S, Choe PG, Song KH, Park SW, Kim HB, Kim NJ, et al. Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia? Antimicrob Agents Chemother. 2011; 55(11):5122-5126. doi: 10.1128/AAC.00485-11 PMID: 21825299
10. Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2008; 52(1):192. PMID: 17984229
11. Chang FY, Peacock JEJ, Musher DM, Triplett P, MacDonald BB, Mylotte JM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine. 2003; 82(5):333-339. PMID: 14530782
12. Chan KE, Warren HS, Thadhani RI, Steele DJ, Hymes JL, Maddux FW, et al. Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD. J Am Soc Nephrol. 2012; 23:1551-1559. doi: 10.1681/ASN.2012010050 PMID: 22904350
13. González C, Rubio M, Romero-Vivas J, González M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis. 1999; 29(5):1171-1177. PMID: 10524959
14. Stryjewski ME, Szcech LA, Benjamin DK, Inrig JK, Kanafani ZA, Engemann JJ, et al. Use of vancomycin of first generation cephalosporins for the treatment of hemodialysis dependent patients with methicillin-susceptibile Staphylococcus aureus bacteremia. Clin Infect Dis. 2006; 44:190-196. PMID: 17173215
15. Schweizer ML, Furuno J, Harris AD, Johnson JK, Shardell MD, McGregor JC, et al. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis. 2011; 11(279):1-7.
16. McDanel JS, Perencevich EN, Diekema DJ, Herwaldt LA, Smith TC, Chrischilles EA, et al. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals. Clin Infect Dis. 2015; 61(3):361-367. doi: 10.1093/cid/civ308 PMID: 25900170
17. Lee CE, Zembower TR, Fotis MA, Postelnick MJ, Greenberger PA, Peterson LR, et al. The incidence of antimicrobial allergies in hospitalized patients: implication regarding prescribing patters and emerging bacterial resistance. Arch Int Med. 2000; 160(18):2819-2822.
18. Solensky R, Khan D. Drug Allergy: An Updated Practice Parameter. Ann Allergy Asthma Immunol.2010; 105(4):259-273. doi: 10.1016/j.anai.2010.08.002 PMID: 20934625
19. Arroliga ME, Wagner W, Bobek MB, Hoffman-Hogg L, Gordon SM, Arroliga AC. A pilot study of penicillin skin testing in patients with a history of penicillin allergy admitted to the medical ICU. Chest. 2000; 118(4):1106-1108. PMID: 11035685
20. Macy E, Ngor E. Safely diagnosing clinically significant penicillin allergy using only penicilloyl-polylysine. J Allergy Clin Immunol Pract. 2013; 1(3):258-263. doi: 10.1016/j.jaip.2013.02.002 PMID: 24565482
21. Rimawi RH, Cook PP, Gooch M, Kabchi B, Ashraf MS, Rimawi BH, et al. The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med. 2013; 8(6):341-345. doi: 10.1002/jhm.2036 PMID: 23553999
22. del Real GA, Rose ME, Ramirez-Atamoros MT, Hammel J, Gordon SM, Arroliga AC, et al. Penicillin skin testing in patients with a history of beta-lactam allergy. Ann Allergy Asthma Immunol. 2007 98(4):355-359. PMID: 17458432
23. Raja AS, Lindsell CJ, Bernstein JA, Codispoti CD, Moellman JJ. The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting. Ann Emerg Med. 2009; 54(1):72-77. doi: 10.1016/j.annemergmed.2008.12.034 PMID: 19217696
24. Bourke J, Pavlos R, James I, Phillips E. Improving the Effectiveness of Penicillin Allergy De-labeling. J Allergy Clin Immunol Pract. 2015; 3(3):365-334 e361. doi: 10.1016/j.jaip.2014.11.002 PMID: 25609352
25. Lopez-Cortes LE, Del Toro MD, Galvez-Acebal J, Bereciartua-Bastarrica E, Fariñas MC, Sanz-Franco M, et al. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013; 57(9):1225-1233. doi: 10.1093/cid/cit499 PMID: 23929889
26. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015; 132(15):1435-1486. doi: 10.1161/CIR.0000000000000296 PMID: 26373316
27. Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis. 2015; 60(10):1451-1461. doi: 10.1093/cid/civ120 PMID: 25701854
28. Rieg S, Peyerl-Hoffmann G, de With K, Theilacker C, Wagner D, Hübner J, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation - a study of 521 patients in Germany. J Infect. 2009; 59(4):232-239. doi: 10.1016/j.jinf.2009.07.015 PMID: 19654021
29. Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008; 46(7):1000-1008. doi: 10.1086/529190 PMID: 18444816
30. Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010; 123(7):631-637. doi: 10.1016/j.amjmed.2010.01.015 PMID: 20493464
31. Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA. 2014; 312(13):1330-1341. doi: 10.1001/jama.2014.9743 PMID: 25268440
32. Dodek P, Phillips P. Questionable history of immediate-type hypersensitivity to penicillin in Staphylococcal endocarditis: treatment based on skin-test results vers-us empirical alternative treatment - A decision analysis. Clin Infect Dis. 1999; 29(5):1251-1256. PMID: 10524971
33. Blumenthal KG, Parker RA, Shenoy ES, Walensky RP. Improving clinical outcomes in patients with methicillin-sensitive Staphylococcus aureus bacteremia and reported penicillin allergy. Clin Infect Dis. 2015; 61(5):741-749. doi: 10.1093/cid/civ394 PMID: 25991471
34. Pickering LK, Baker CJ, Kimberlin DW. Red Book: Report of the Committee on Infectious Diseases. 29th Edition ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
35. Blumenthal KG, Shenoy ES, Varughese CA, Hurwitz S, Hooper DC, Banerji A. Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy. Ann Allergy Asthma Immunol. 2015; 115(4):294-300 e292. doi: 10.1016/j.anai.2015.05.011 PMID: 26070805
36. Blumenthal KG, Shenoy ES, Hurwitz S, Varughese CA, Hooper DC, Banerji A. Effect of a drug allergy educational program and antibiotic prescribing guideline on inpatient clinical providers' antibiotic prescribing knowledge. J Allergy Clin Immunol Pract. 2014; 2(4):407-413. doi: 10.1016/j.jaip.2014.02.003 PMID: 25017528
37. Barr DA, Semple L, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents. 2012; 39(5):407-413. doi: 10.1016/j.ijantimicag.2012.01.016 PMID: 22445493
38. Cox AM, Malani PN, Wiseman SW, Kauffman CA. Home intravenous antimicrobial infusion therapy: a viable option in older adults. J Am Geriatr Soc. 2007; 55(5):645-650. PMID: 17493182
39. Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010; 51 Suppl 2:S198-208. doi: 10.1086/653520 PMID: 20731577
40. Chapman AL, Dixon S, Andrews D, Lillie PJ, Bazaz R, Patchett JD. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009; 64(6):1316-1324. doi: 10.1093/jac/dkp343 PMID: 19767623
41. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics. 2005; 115(4):1048-1057. PMID: 15805383
42. Pichichero ME. Cephalosporins can be prescribed safely for penicillin-allergic patients. J Fam Pract. 2006; 55(2):106-112. PMID: 16451776
43. Pichichero ME. Use of selected cephalosporins in penicillin- allergic patients: a paradigm shift. Diagn Microbiol Infect Dis. 2007; 57(3 Suppl):13S-18S. PMID: 17349459
44. Macy E, Contreras R. Adverse reactions associated with oral and parenteral use of cephalosporins: A retrospective population-based analysis. J Allergy Clin Immunol. 2015; 135(3):745-752 e745. doi: 10.1016/j.jaci.2014.07.062 PMID: 25262461
45. Earl HS, Casey WC, Gruchalla RS. Safety of cephalosporin administration to patients with histories of penicillin allergy. J Allergy Clin Immunol. 2004; 113(6):1220-1222. PMID: 15214363
46. Goodman EJ, Morgan MJ, Johnson PA, Nichols BA, Denk N, Gold BB. Cephalosporins can be given to penicillin-allergic patients who do not exhibit an anaphylactic response. J Clin Anesth. 2001; 13(8):561-564. PMID: 11755324
47. Davis L. Representative for Pre-Pen, ALK by email, Spetember 30, 2013. 2013.
48. American Academy Of Allergy Asthma, and Immunology. Find an Allergist/Immunologist. 2015. Available: http://allergist.aaaai.org/find/. Accessed 14 December 2015.
49. Forrest DM, Schellenberg RR, Thien VV, King S, Anis AH, Dodek PM. Introduction of a practice guideline for penicillin skin testing improves the appropriateness of antibiotic therapy. Clin Infect Dis. 2001; 32(12):1685-1690. PMID: 11360207
50. Wickern GM, Nish WA, Bitner AS, Freeman TM. Allergy to beta-lactams: a survey of current practices. J Allergy Clin Immunol. 1994; 94(4):725-731. PMID: 7930306
51. Prematta T, Shah S, Ishmael FT. Physician approaches to beta-lactam use in patients with penicillin hypersensitivity. Allergy Asthma Proc. 2012; 33(2):145-151. doi: 10.2500/aap.2012.33.3526 PMID: 22525391
52. Banks TA, Ressner RA, Gada SM. Antibiotic reclamation: penicillin allergy, antibiotic stewardship, and the allergist. Ann Allergy Asthma Immunol. 2015; 115(5):451-452. doi: 10.1016/j.anai.2015.08.008 PMID: 26386657
53. Ressner RA, Gada SM, Banks TA. Antimicrobial stewardship and the allergist: reclaiming our antibiotic armamentarium. Clin Infect Dis. 2016; 62(3):400-401. doi: 10.1093/cid/civ886 PMID: 26486707